OpenCharities

UK Breast Cancer Group (Ukbcg)

Ukbcg

Country
England & Wales
Charity number
1177296
Status
Registered
Registered
Feb. 23, 2018
Legal form
CIO

Address

Address
UKBCG SECRETARIAT
C/O PROFILE PRODUCTIONS
SUITE 213 BOUNDARY HOUSE
BOSTON ROAD
LONDON
W7 2QE

Contact

Activities

Holds an annual educational meeting. A NICE stakeholder.Dissemination of information in the field of breast cancer.

Objects: The Objects Of The CIO Are:- For The Public Benefit To Advance The Education Of Consultant Clinical And Medical Oncologists And Associated Healthcare Professionals In The Subject Of Breast Cancer, Concerning Its Identification, Diagnosis And Treatment - In Furtherance Of The Above, To Promote Research For The Public Benefit In All Aspects Of That Subject And To Publish The Useful Results.- The Relief Of Sickness And Preservation Of Health, From Breast Cancer, Among People Residing Permanently Or Temporarily In The UK.- To Assist In The Treatment And Care Of Persons Suffering From Breast Cancer, Or In Need Of Rehabilitation, By The Provision Of Education For Healthcare Professionals.- To Promote And Protect The Physical And Mental Health Of Sufferers Of Breast Cancer In The UK, Through The Provision Of Education And Advice.

Classification

How
Provides Advocacy/advice/information, Sponsors Or Undertakes Research, Acts As An Umbrella Or Resource Body
What
General Charitable Purposes, Education/training, The Advancement Of Health Or Saving Of Lives, Disability
Who
The General Public/mankind

Areas of operation

Country
Northern Ireland, Scotland
Region
Throughout England And Wales

Finances

Period end Income Expenditure
Dec. 31, 2024 £346,730 £316,840
Dec. 31, 2023 £280,495 £281,478
Dec. 31, 2022 £165,137 £231,310
Dec. 31, 2021 £132,055 £73,409
Dec. 31, 2020 £84,000 £64,461

Trustees

Name Appointed
Prof Mark Beresford (Chair) Feb. 23, 2018
Dr ANGUS WHEATLEY Feb. 23, 2018
Dr Andreas Makris Feb. 23, 2018
Dr CATHERINE HARPER-WYNNE MD, FRCP Feb. 23, 2018
Dr IAIN MACPHERSON Feb. 23, 2018
Dr Judy King Jan. 24, 2025